XFOREST Trademark

Trademark Overview


On Wednesday, October 28, 2020, a trademark application was filed for XFOREST with the United States Patent and Trademark Office. The USPTO has given the XFOREST trademark a serial number of 90284105. The federal status of this trademark filing is REGISTERED as of Tuesday, March 22, 2022. This trademark is owned by xFOREST Therapeutics Co., Ltd.. The XFOREST trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Provision of consultancy, advice, and information regarding testing, inspection, and research of pharmaceuticals; Provision of consultancy, advice, and information regarding pharmaceutical and drug development; Pharmaceutical drug development services; Pharmaceutical products development; Conducting clinical trials for others relating to pharmaceuticals; Provision of consultancy, advice, and information regarding clinical trials of pharmaceuticals; Research and development in the field of diagnostic agents
xforest

General Information


Serial Number90284105
Word MarkXFOREST
Filing DateWednesday, October 28, 2020
Status700 - REGISTERED
Status DateTuesday, March 22, 2022
Registration Number6675089
Registration DateTuesday, March 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements


Certificate of Correction for RegistrationIn the statement, line 1, " xFOREST Therapeutics Co., Ltd., Creation core Kyoto Mikuruma 214" should be deleted, and xFOREST Therapeutics Co., Ltd., should be inserted.
Pseudo MarkX FOREST
Goods and ServicesProvision of consultancy, advice, and information regarding testing, inspection, and research of pharmaceuticals; Provision of consultancy, advice, and information regarding pharmaceutical and drug development; Pharmaceutical drug development services; Pharmaceutical products development; Conducting clinical trials for others relating to pharmaceuticals; Provision of consultancy, advice, and information regarding clinical trials of pharmaceuticals; Research and development in the field of diagnostic agents

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 18, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamexFOREST Therapeutics Co., Ltd.,
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressKamigyo-ku, Kyoto-shi, Kyoto 602-0841
JP

Party NamexFOREST Therapeutics Co., Ltd.,
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressKamigyo-ku, Kyoto-shi, Kyoto 602-0841
JP

Party NamexFOREST Therapeutics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressKyoto 606-8304
JP

Trademark Events


Event DateEvent Description
Tuesday, February 28, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Friday, January 20, 2023CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, January 19, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 12, 2022TEAS SECTION 7 REQUEST RECEIVED
Tuesday, March 22, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, February 10, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, February 7, 2022ASSIGNED TO PETITION STAFF
Monday, January 31, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 1, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2021NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2021NON-FINAL ACTION WRITTEN
Monday, July 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 26, 2021ASSIGNED TO LIE
Monday, July 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 2, 2021NON-FINAL ACTION E-MAILED
Friday, April 2, 2021NON-FINAL ACTION WRITTEN
Monday, March 29, 2021ASSIGNED TO EXAMINER
Friday, December 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 2, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, November 2, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, November 1, 2020NEW APPLICATION ENTERED